A novel, stable, helical scaffold as an alternative binder - construction of phage display libraries

Acta Biochimica Polonica

Volumn 59, Issue 3, 2012, Pages 383-390

  Cyranka Czaja, Anna ^a   Otlewski, Jacek ^a  

^a UNIVERSITY OF WROC AW   (Poland)

Author keywords

Alternative scaffold; Construction of phage libraries; Phage display

Indexed keywords

EID: 84873712142     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2012_2126     Document Type: Article

References (38)

1. Amstutz P, Forrer P, Zahnd C, Pluckthun A (2001) In vitro display technologies: novel developments and applications. Curr Opin Biotechnol 12: 400-405.
2. Barbas CF 3rd (1995) Synthetic human antibodies. Nat Med 1: 837-839.
3. Binz HK, Amstutz P, Kohl A, Stumpp MT, Briand C, Forrer P, Grutter MG, Pluckthun A (2004) High-affinity binders selected from designed ankyrin repeat protein libraries. Nat Biotechnol 22: 575-582.
4. Binz HK, Amstutz P, Pluckthun A (2005) Engineering novel binding proteins from nonimmunoglobulin domains. Nat Biotechnol 23: 1257-1268.
5. Binz HK, Pluckthun A (2005) Engineered proteins as specific binding reagents. Curr Opin Biotechnol 16: 459-469.
6. Blanchard L, Tarbouriech N, Blackledge M, Timmins P, Burmeister WP, Ruigrok RW, Marion D (2004) Structure and dynamics of the nucleocapsid-binding domain of the Sendai virus phosphoprotein in solution. Virology 319: 201-211.
7. Emberley ED, Murphy LC, Watson PH (2004) S100A7 and the progression of breast cancer. Breast Cancer Res 6: 153-159.
8. Fellouse FA, Barthelemy PA, Kelley RF, Sidhu SS (2006) Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code. J Mol Biol 357: 100-114.
9. Fellouse FA, Wiesmann C, Sidhu SS (2004) Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc Natl Acad Sci USA 101: 12467-12472.
10. Friedman M, Orlova A, Johansson E, Eriksson TL, Hoiden-Guthenberg I, Tolmachev V, Nilsson FY, Stahl S (2008) Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule. J Mol Biol 376: 1388-1402.
11. Kesting MR, Sudhoff H, Hasler RJ, Nieberler M, Pautke C, Wolff KD, Wagenpfeil S, Al-Benna S, Jacobsen F, Steinstraesser L (2009) Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncology 45: 731-736.
12. Kingston RL, Gay LS, Baase WS, Matthews BW (2008) Structure of the nucleocapsid-binding domain from the mumps virus polymerase; an example of protein folding induced by crystallization. J Mol Biol 379: 719-731.
13. Koide A, Bailey CW, Huang X, Koide S (1998) The fibronectin type III domain as a scaffold for novel binding proteins. J Mol Biol 284: 1141-1151.
14. Koide A, Gilbreth RN, Esaki K, Tereshko V, Koide S (2007) Highaffinity single-domain binding proteins with a binary-code interface. Proc Natl Acad Sci USA 104: 6632-6637.
15. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
16. Lendel C, Dogan J, Hard T (2006) Structural basis for molecular recognition in an affibody:affibody complex. J Mol Biol 359: 1293-1304.
17. Ling MM (2003) Large antibody display libraries for isolation of highaffinity antibodies. Combinatorial Chemistry & High Throughput Screening 6: 421-432.
18. Longhi S, Receveur-Brechot V, Karlin D, Johansson K, Darbon H, Bhella D, Yeo R, Finet S, Canard B (2003) The C-terminal domain of the measles virus nucleoprotein is intrinsically disordered and folds upon binding to the C-terminal moiety of the phosphoprotein. J Biol Chem 278: 18638-18648.
19. Lucast LJ, Batey RT, Doudna JA (2001) Large-scale purification of a stable form of recombinant tobacco etch virus protease. BioTechniques 30: 544-546 548-550 passim.
20. Milovnik P, Ferrari D, Sarkar CA, Pluckthun A (2009) Selection and characterization of DARPins specific for the neurotensin receptor 1. Protein Engineering Design & Selection 22: 357-366.
21. Morgan MR, Jazayeri M, Ramsay AG, Thomas GJ, Boulanger MJ, Hart IR, Marshall JF (2011) Psoriasin (S100A7) associates with integrin beta6 subunit and is required for alphavbeta6-dependent carcinoma cell invasion. Oncogene 30: 1422-1435.
22. Nord K, Gunneriusson E, Ringdahl J, Stahl S, Uhlen M, Nygren PA (1997) Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nature Biotechnol 15: 772-777.
23. Nygren PA (2008) Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold. FEBS J 275: 2668-2676.
24. Nygren PA, Uhlen M (1997) Scaffolds for engineering novel binding sites in proteins. Curr Opin Struct Biol 7: 463-469.
25. Orlova A, Magnusson M, Eriksson T.L, Nilsson M, Larsson B, Hoiden-Guthenberg I, Widstrom C, Carlsson J, Tolmachev V, Stahl S, Nilsson FY (2006) Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res 66: 4339-4348.
26. Russel M LH, Clackson T (2004) Introduction to phage biology and phage display. In Phage Display: A Practical Approach. Oxford university Press.
27. Sidhu SS, Kossiakoff AA (2007) Exploring and designing protein function with restricted diversity. Current Opin Chem Biol 11: 347-354.
28. Skerra A (2007) Alternative non-antibody scaffolds for molecular recognition. Current Opin Biotechnol 18: 295-304.
29. Smith GP (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228: 1315-1317.
30. Smith GP, Scott JK (1993) Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol 217: 228-257.
31. Steiner D, Forrer P, Pluckthun A (2008) Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display. J Mol Biol 382: 1211-1227.
32. Steiner D, Forrer P, Stumpp MT, Pluckthun A (2006) Signal sequences directing cotranslational translocation expand the range of proteins amenable to phage display. Nat Biotechnol 24: 823-831.
33. Tamaskovic R, Simon M, Stefan N, Schwill M, Pluckthun A (2012) Designed ankyrin repeat proteins (DARPins) from research to therapy. Methods Enzymol 503: 101-134.
34. Wahlberg E, Lendel C, Helgstrand M, Allard P, Dincbas-Renqvist V, Hedqvist A, Berglund H, Nygren PA, Hard T (2003) An affibody in complex with a target protein: structure and coupled folding. Proc Natl Acad Sci USA 100: 3185-3190.
35. Wikman M, Steffen A.C, Gunneriusson E, Tolmachev V, Adams G.P, Carlsson J, Stahl S (2004) Selection and characterization of HER2/ neu-binding affibody ligands. Protein Engineering Design & Selection 17: 455-462.
36. Wojcik J, Hantschel O, Grebien F, Kaupe I, Bennett K.L, Barkinge J, Jones R.B, Koide A, Superti-Furga G, Koide S (2010) A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nat Struct Mol Biol 17: 519-527.
37. Zahnd C, Pecorari F, Straumann N, Wyler E, Pluckthun A (2006) Selection and characterization of Her2 binding-designed ankyrin repeat proteins. J Biol Chem 281 35167-35175.
38. Zahnd C, Wyler E, Schwenk JM, Steiner D, Lawrence MC, McKern NM, Pecorari F, Ward CW, Joos TO, Pluckthun A (2007) A designed ankyrin repeat protein evolved to picomolar affinity to Her2. J Mol Biol 369: 1015-1028.